Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Jensen

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
Small cell and its stroma: determinant of pan-resistance?Maxwell Sehested, Peter B. Jensen
Nature Reviews. Genetics|December 19, 2012
Reply to 'Mining electronic health records: an additional perspective'Peter B Jensen, Lars J Jensen, Søren Brunak
Nature Reviews. Genetics|May 3, 2012
Mining electronic health records: towards better research applications and clinical carePeter B Jensen, Lars J Jensen, Søren Brunak
Biophysical Journal|March 23, 2010
A Wnt oscillator model for somitogenesisPeter B Jensen, Lykke Pedersen, Sandeep Krishna, et al.
The Lancet. Oncology|June 18, 2002
Culprit and victim -- DNA topoisomerase IIUdo Kellner, Maxwell Sehested, Peter B Jensen, et al.
European Journal of Public Health|August 28, 2020
Primary care visits can reduce the risk of potentially avoidable hospitalizations among persons with diabetes in FranceVera Georgescu, Anders Green, Peter B Jensen, et al.
Biochemical and Biophysical Research Communications|August 2, 2005
Separation of bisdioxopiperazine- and vanadate resistance in topoisomerase IITina K Sorensen, Morten Grauslund, Peter B Jensen, et al.
Biochemistry|August 13, 2003
Analysis of bisdioxopiperazine dexrazoxane binding to human DNA topoisomerase II alpha: decreased binding as a mechanism of drug resistanceAxelle Renodon-Cornière, Lars H Jensen, John L Nitiss, et al.
Biochemistry|November 6, 2002
Interaction of human DNA topoisomerase II alpha with DNA: quantification by surface plasmon resonanceAxelle Renodon-Cornière, Lars H Jensen, John L Nitiss, et al.
Experimental Hematology|July 4, 2020
Characterization of resistance to a recombinant hexameric Fas-ligand (APO010) in human cancer cell linesHaatisha Jandu, Annette Nielsen, Nils Brunner, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
Small cell and its stroma: determinant of pan-resistance?Maxwell Sehested, Peter B. Jensen
Nature Reviews. Genetics|December 19, 2012
Reply to 'Mining electronic health records: an additional perspective'Peter B Jensen, Lars J Jensen, Søren Brunak
Nature Reviews. Genetics|May 3, 2012
Mining electronic health records: towards better research applications and clinical carePeter B Jensen, Lars J Jensen, Søren Brunak
Biophysical Journal|March 23, 2010
A Wnt oscillator model for somitogenesisPeter B Jensen, Lykke Pedersen, Sandeep Krishna, et al.
The Lancet. Oncology|June 18, 2002
Culprit and victim -- DNA topoisomerase IIUdo Kellner, Maxwell Sehested, Peter B Jensen, et al.
European Journal of Public Health|August 28, 2020
Primary care visits can reduce the risk of potentially avoidable hospitalizations among persons with diabetes in FranceVera Georgescu, Anders Green, Peter B Jensen, et al.
Biochemical and Biophysical Research Communications|August 2, 2005
Separation of bisdioxopiperazine- and vanadate resistance in topoisomerase IITina K Sorensen, Morten Grauslund, Peter B Jensen, et al.
Biochemistry|August 13, 2003
Analysis of bisdioxopiperazine dexrazoxane binding to human DNA topoisomerase II alpha: decreased binding as a mechanism of drug resistanceAxelle Renodon-Cornière, Lars H Jensen, John L Nitiss, et al.
Biochemistry|November 6, 2002
Interaction of human DNA topoisomerase II alpha with DNA: quantification by surface plasmon resonanceAxelle Renodon-Cornière, Lars H Jensen, John L Nitiss, et al.
Experimental Hematology|July 4, 2020
Characterization of resistance to a recombinant hexameric Fas-ligand (APO010) in human cancer cell linesHaatisha Jandu, Annette Nielsen, Nils Brunner, et al.
Pageof 3